Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagiaHAGAN, M. M; MOSS, D. E.Peptides (New York, NY. 1980). 1994, Vol 15, Num 2, pp 243-245, issn 0196-9781Article

Molecular and crystal structures of two β-bend forming monothiated analogues of melanostatinBARDI, R; PIAZZESI, A. M; TONIOLO, C et al.Tetrahedron (Oxford. Print). 1988, Vol 44, Num 3, pp 761-769, issn 0040-4020Article

DEGRADATION OF MELANOTROPIN INHIBITING FACTOR BY BRAINHUI KS; CHENG KP; WONG KH et al.1980; J. NEUROCHEM.; GBR; DA. 1980; VOL. 35; NO 2; PP. 471-478; BIBL. 30 REF.Article

SYNTHESIS OF ANALOGUES OF THE MELANOCYTE-STIMULATING HORMONE RELEASE-INHIBITING FACTOR CONTAINING 2-OXOIMIDAZOLIDINE-1-CARBOXYLIC ACIDKASAFIREK E; KREJCI I; FELT V et al.1980; COLLECT. CZECH. CHEM. COMMUN.; ISSN 0010-0765; CSK; DA. 1980; VOL. 45; NO 1; PP. 294-297; BIBL. 18 REF.Article

Semi-synthesis of melanocyte-stimulating hormone (MSH) release-inhibiting hormone from Pro-Leu and Gly-NH₂ by the protease from Streptomyces cellulosaeMURO, T; TOMINAGA, Y; OKADA, S et al.Agricultural and biological chemistry. 1987, Vol 51, Num 4, pp 1207-1208, issn 0002-1369Article

Evidence for conversion of N-Tyr-MIF-1 into MIF-I by a specific brain aminopeptidaseMARKS, N; BERG, M. J; KASTIN, A. J et al.Neurochemistry international. 1984, Vol 6, Num 3, pp 347-353, issn 0197-0186Article

Improvement in major depression after low subcutaneous doses of MIF-1EHRENSING, R. H; KASTIN, A. J; WURZLOW, G. F et al.Journal of affective disorders. 1994, Vol 31, Num 4, pp 227-233, issn 0165-0327Article

Saturable transport of peptides across the blood-brain barrierBANKS, W. A; KASTIN, A. J.Life sciences (1973). 1987, Vol 41, Num 11, pp 1319-1338, issn 0024-3205Article

Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1 : comparison with morphineBANKS, W. A; KASTIN, A. J.Peptides (New York, NY. 1980). 1994, Vol 15, Num 1, pp 23-29, issn 0196-9781Article

ELECTRON IMPACT AND METHANE, ISOBUTANE AND AMMONIA CHEMICAL IONIZATION MASS SPECTRA OF PEPTIDE AMIDES RELATED TO MELANOSTATIN (PRO-LEU-GLY-NH₂)BJORKMAN S.1982; BIOMEDICAL MASS SPECTROMETRY; ISSN 0306-042X; GBR; DA. 1982; VOL. 9; NO 8; PP. 315-322; BIBL. 25 REF.Article

SOME QUESTIONS RELATED TO MELANOCYTE-STIMULATING HORMONE.KASTIN AJ; SANDMAN CA; MILLER LH et al.1976; MAYO CLIN. PROC.; U.S.A.; DA. 1976; VOL. 51; NO 9-10; PP. 632-636; BIBL. 71 REF.Article

Rapid clinical effectiveness of MIF-I in the treatment of major depressive illnessVAN DER VELDE, C. D.Peptides (New York, NY. 1980). 1983, Vol 4, Num 3, pp 297-300, issn 0196-9781Article

THEORETICAL STUDIES ON PRO-LEU-GLY-NH₂ CONFORMATION.SUNGZONG KANG; WALTER R.1976; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1976; VOL. 73; NO 4; PP. 1203-1206; BIBL. 17 REF.Article

MIF-1: EFFECTS ON NOREPINEPHRINE, DOPAMINE AND SEROTONIN METABOLISM IN CERTAIN DISCRETE BRAIN REGIONSSINGHAL RL; RASTOGI RB.1982; PHARMACOL. BIOCHEM. BEHAV.; ISSN 0091-3057; USA; DA. 1982; VOL. 16; NO 2; PP. 229-233; BIBL. 33 REF.Article

SOME OBSERVATIONS ON THE PHARMACOLOGICAL ACTIVITY OF MIF (PRO-LEU-GLY-NH₂)TURNBULL MJ; WHEELER H.1980; J. PHARM. PHARMACOL.; ISSN 0022-3573; USA; DA. 1980; VOL. 32; NO 11; PP. 803-804; BIBL. 4 REF.Article

IDENTIFICATION OF MSH RELEASE-INHIBITING ELEMENTS IN THE NEUROINTERMEDIATE LOBE OF THE RATTILDERS FJH; VAN DER WOUDE HA; SWAAB DF et al.1979; BRAIN RES.; NLD; DA. 1979; VOL. 171; NO 3; PP. 425-435; BIBL. 32 REF.Article

CONFORMATIONAL ENERGY ANALYSIS OF MELANOSTATINZIMMERMAN SS; BAUM R; SCHERAGA HA et al.1982; INT. J. PEPT. PROTEIN. RES.; ISSN 0367-8377; DNK; DA. 1982; VOL. 19; NO 2; PP. 143-152; BIBL. 33 REF.Article

LASER RAMAN STUDIES ON THE CONFORMATION OF PRO-LEU-GLY-NH₂HSEU TH; CHANG H.1980; BIOCHIM. BIOPHYS. ACTA; NLD; DA. 1980; VOL. 624; NO 2; PP. 340-345; BIBL. 16 REF.Article

Developmental, behavioral, and opiate receptor changes after prenatal or postnatal β-endorphin, CRF, or Tyr-MIF-1ZADINA, J. E; KASTIN, A. J; COY, D. H et al.Psychoneuroendocrinology. 1985, Vol 10, Num 4, pp 367-383, issn 0306-4530Article

Tyr-MIF-1 and Met-enkephalin share a saturable blood-brain barrier transport systemBANKS, W. A; KASTIN, A. J; MICHALS, E. A et al.Peptides (New York, NY. 1980). 1987, Vol 8, Num 5, pp 899-903, issn 0196-9781Article

MIF-1 and Tyr-MIF-1 augment GABA-stimulated benzodiazepine receptor bindingMILLER, L. G; KASTIN, A. J.Peptides (New York, NY. 1980). 1987, Vol 8, Num 5, pp 751-755, issn 0196-9781Article

Dopamine receptor antagonists block the effecxt of TYR-MIF-1 (TYR-PRO-LEU-GLY-NH₂) on the opioate form of footshock-induced analgesiaKROWICKI, Z. K.Neuropeptides (Edinburgh). 1991, Vol 19, Num 4, pp 281-285, issn 0143-4179Article

An NPY-like peptide may function as MSH-release inhibiting factor in Xenopus laevisLIDY VERBURG-VAN KEMENADE, B. M; JENKS, B. G; DANGER, J.-M et al.Peptides (New York, NY. 1980). 1987, Vol 8, Num 1, pp 61-67, issn 0196-9781Article

Melanocyte-stimulating hormone release-inhibiting factor-1 (MIF-1) can be formed form Tyr-MIF-1 in brain mitochondrial but not in brain homogenateKASTIN, A. J; HAHN, K; ZADINA, J. E et al.Journal of neurochemistry. 1995, Vol 64, Num 4, pp 1855-1859, issn 0022-3042Article

Effects of melanostatine (MIF-1) on focal potentials in slices of rat brain cortexMOKRUSHIN, A. A; EMELYANOV, N. A.Neuropeptides (Edinburgh). 1991, Vol 20, Num 2, pp 87-94, issn 0143-4179Article